You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation

Article metrics

Article menu
Download PDFPDF
Letter
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 2021607600135
Jun 202121121136
Jul 2021646422
Aug 2021646548
Sep 202139739977
Oct 202119319379
Nov 2021666750
Dec 2021383824
Jan 2022505030
Feb 2022383722
Mar 2022293317
Apr 2022383621
May 2022383830
Jun 2022363419
Jul 202225236
Aug 2022353510
Sep 2022313111
Oct 2022242413
Nov 2022222212
Dec 202215153
Jan 2023202019
Feb 202339395
Mar 2023998
Apr 20232600
May 20233532
Jun 20232603
Jul 20232821
Aug 2023800
Sep 20231400
Oct 20232711
Nov 20232710
Dec 20232711
Jan 20241900
Feb 20241933
Mar 20242710
Total23722095708